Doctor_Frank_Rocco has no public, corporate or medical
Doctor_Frank_Rocco has no public, corporate or medical credentials tied to that name other than having a presence as an online account. The trolls and bad guys trying to hurt CYDY and therefor its share price are tending to attempt to intimidate or influence posters here directly with DMs, rather than publicly, where their denigrating posts will be promptly deleted.
Attempting to stop or slow down the progress of leronlimab is amoral and can cause the deaths and morbidity of a great many people.
If you get a DM with tangential, typically false statements- Don't feed the bears. Ignore them and they'll go away only to return with some other farcical derogatory attempt that they are apparently getting paid for.
The posters here know what they know and are very eager to understand what the first good studies will display for leronlimab.
Don't allow some clown show, non-factual, misstating post, either direct or public influence what you understand about the drug.
Leronlimab is for real.. These posters from doom are not.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Growing Pains of Teen Driving Getting a driver's license is exciting for teens, but let's face it—the road is no playground. In 2024, a staggering 2,320 lives were lost in the U.S. due to crashes with teen drivers at the wheel. These stats aren’t just numbers—they’re grim reminders that safety isn’t a given for young drivers. Amidst this backdrop, the...
Continue Reading
A Rocky Day for Endava Investors Here's the thing, on September 21, 2026, Endava plc hit a rough patch that left a mark. After the market closed, the company announced that it had put its Chief Financial Officer, Mark Thurston, on administrative leave. This wasn't just a routine shuffle; it came on the heels of the Board's Audit Committee finding reason to probe into...
Continue Reading
Car-Buying Matrix: Digital Tools and Physical Showrooms Let me tell ya, even as we're up to our eyeballs in tech, seems like folks still can't wean off the good ol' car dealership. Over 80% of car buyers toss a mix of online and in-person sleuthing into the deal, yet nine out of ten won't take the plunge till they've shaken a dealer's hand. Why's that? Trust? Habit? Who...
Continue Reading
Hyliion's Rocky Partnership Sparks Market Concern If you've got your cash tied up in Hyliion Holdings Corp. (NYSE: HYLN), you've probably got an eye twitch by now. Last June, a damning report from Pelican Way Research threw a wrench in Hyliion's plans with VFG Holdings, calling into question the whole commercial rationale of their newest partnership. Imagine staking $133...
Continue Reading
Cold Weather is All About Precaution It ain't the first day at the fair when you realize winter's sneaking up, and with it, the looming concern of older family members hunkering down indoors. Executive Home Care's calling out, saying it straight: if you've got seniors in your midst, now's the time to batten down the hatches. The winter months can turn into a slippery...
Continue Reading
Anita Eno's Well-Deserved Recognition You've got to respect a story where someone claws their way up from humble beginnings to a position of serious influence. Anita Eno, Founder and CEO of Prayers Are Answered Inc., is one of those impressive figures, recently bagging the 2027 American Business Woman of the Year title. This accolade, dished out by the American Business...
Continue Reading
Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...
Continue Reading
A New Chapter for JinkoSolar Right out of the gate, JinkoSolar has decided to shake things up, along with a new legal identity. The news coming from their 2026 annual general meeting confirms a significant shift in branding from ‘JinkoSolar Holding Co., Ltd’ to the new title of ‘Jinko Holdings Limited’. If you’ve been around the block like me, you’ll know that...
Continue Reading
A New Stage in China's Financial Opening-Up China's making some serious waves in the financial seas this week, kicking off the Annual Conference of the Financial Street Forum 2026 in Beijing. The big guns from China's financial regulatory bodies are rolling out policies with one clear message: they’re serious about opening up. They're launching pilot initiatives like...
Continue Reading
Investors Land in Hot Water with Ardelyx Alright, folks, here we go again. New York's courtroom dramas are in full swing with Ardelyx, Inc. at center stage, and not in a good way. The DJS Law Group has rallied the troops, reminding investors caught in the storm of a class action lawsuit. Specifically, it's all about alleged violations of the Securities Exchange Act of...
Continue Reading
Top 5 Most Recently Viewed Articles
Abeona Therapeutics Grants New Employee Equity Awards Abeona Therapeutics Inc. recently made a significant announcement regarding new equity awards for its employees. These awards are in line with Nasdaq Listing Rule 5635(c)(4) and were granted to non-executive employees who joined the company. This move showcases the company's commitment to attracting top talent in the...
Continue Reading
American Battery Technology Company Reports Impressive Financial Growth American Battery Technology Company (ABTC) (NASDAQ: ABAT) is proudly celebrating a significant milestone: its first revenue from the sale of recycled lithium-ion batteries to the domestic manufacturing sector. This achievement not only marks a success for ABTC but also represents a crucial step...
Continue Reading
Branch Celebrates Ranking on Deloitte Technology Fast 500 Recognized in the 2025 list, Branch stands out as a leader in workforce payments. Branch, the leading workforce payments platform, has recently announced its impressive ranking at number 78 on the Deloitte Technology Fast 500—a prestigious list recognizing the fastest-growing technology, media,...
Continue Reading
Overview of aTyr Pharma's Recent Challenges aTyr Pharma, Inc. (NASDAQ: ATYR), based in San Francisco, recently faced a significant downturn when its stock plummeted over 80%. The catalyst for this dramatic decline was the outcomes of their EFZO-FIT late-stage clinical trial aimed at evaluating efzofitimod for the treatment of pulmonary sarcoidosis. Notably, this condition...
Continue Reading
Overview of the EV Battery Testing Market The EV battery testing market is on a remarkable trajectory, expected to grow significantly as technological advancements and the demand for electric vehicles (EVs) rise. With a projected growth from USD 3.35 billion to USD 9.51 billion by 2030, the market shows a robust compound annual growth rate (CAGR) of 19.0%. This remarkable...
Continue Reading